A Promise for life

Company portfolio

Brief History

• Founded by Dr. Wallace

calvin abbott in 1888 in

northern Chicago

• company went public in

1929

• Headquarters at north

Chicago, Illinois, USA

Products

• Two major product groups:

a) diversified medical products include diagnostics,

nutritional products, established pharmaceuticals, and

medical devices

b) research-based pharmaceuticals(core line of business)

• Abbott sells its products in 140 countries, employing over

60000 people

• Largest company in nutritional products and second

largest in diagnostic products

• Abbott’s Established Pharmaceuticals Division(EPD)

Established Pharmaceuticals Division(EPD)

• Headquarters Basel, Switzerland

• Net Sales* $5.1 billion

• Global Leadership Across international markets:

a) No.1 macrolide antibiotic

b) No.1 pancreatic enzyme replacement therapy

c) No.1 progestogen product

• Strong positions in key emerging markets

• EPD does not sell or distribute its products in the

United States.

• Strategy involves building a portfolio that best

meets each local market’s needs.

• Portfolio covers therapeutic areas as

gastroenterology, women’s health, cardiology,

metabolic disorders and primary care

*Brand names vary in different countries

Acquisitions and Revenues

• Recently acquired Chile-based CFR

Pharmaceuticals

• Acquired IDEV Technologies, a stent

manufacturing company, for $310

million net of cash and debt

• Abbott India on Thursday posted 71.42%

rise in its net profit to Rs50.93 crore for

the first quarter ended 30 june

•